Growing Revenue, TWST Set to Launch?Digital Health & Medical AI is on the rise ...and so is TWST's Revenue.
It is tipped that artificial intelligence will play a key role in the development of industry wide efficiencies, with many advancements occurring over the last 12 months within the Medical Technologies space.
One key player co
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−3.38 USD
−208.73 M USD
312.97 M USD
56.37 M
About Twist Bioscience Corporation
Sector
Industry
CEO
Emily Marine Leproust
Website
Headquarters
San Francisco
Founded
2013
FIGI
BBG006KDCHJ4
Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas, EMEA, and APAC. The Americas segment consists of the United States of America, Canada, Mexico, and South America. The EMEA segment includes Europe, Middle East, and Africa. The APAC segment focuses on Japan, China, South Korea, India, Singapore, Malaysia, and Australia. The company was founded by William Marine Banyai, Emily Marine Leproust, and Bill James Peck in 2013 and is headquartered in San Francisco, CA.
Long-term bottoms for Position Trade OpportunitiesNASDAQ:TWST reports tomorrow and has been trending up but doesn't have a pre earnings run. However, the stock has completed a long term bottom which provides strong support. Position trade candidate after the earnings volatility settles out. Institutional Holdings are very high.
Twist Biosciences (TWST) AnalysisInnovation and Market Leadership:
Twist Biosciences NASDAQ:TWST , a leader in synthetic DNA products, is set for substantial growth with its new Express Genes service, offering NGS-verified genes in just five to seven business days. This innovation is expected to strengthen Twist's market position
Swing Trading Setups: TWSTThis is a stock that went on my students' watchlists this week for potential swing trading.
NASDAQ:TWST is coming out of a long-term down-trending correction and has completed the bottom. Accumulation ended and a HFT gap and run up followed on May 3rd. The stock retested the sideways trend high
Strategic Insights and Future Aspirations: My Investment JourneyNASDAQ:TWST I researched TWST stock about a year and a half ago, around the beginning of 2023. It was noticeable that there was also a gap that initiated a downward trend, and I waited for the stop squeeze around the $10-12 price range. Unfortunately, due to liquidity issues at that time, I was una
Twist Bioscience - Better Than Expected Both earnings and revenue are better than expected! The reaction is still muted but on the chart we have a beautiful descending triangle with a breakout starting. We could very well back test as we are a bit overbought, we could also just go sideways or up. I have already established an entry but I
Let's do the TWST again - Buy under 29I like the potential of this stock to run up to $42. I'll likely be reanalyzing my sell point often if the stock were to pump upwards after hitting somewhere under 28.18.
I think at some point late in the week, we'll see the dip, and I'll be looking to buy if we can hold support and form a new tre
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of TWST is 36.80 USD — it has decreased by −4.29% in the past 24 hours. Watch Twist Bioscience Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Twist Bioscience Corporation stocks are traded under the ticker TWST.
TWST stock has fallen by −2.75% compared to the previous week, the month change is a −10.53% fall, over the last year Twist Bioscience Corporation has showed a 26.50% increase.
We've gathered analysts' opinions on Twist Bioscience Corporation future price: according to them, TWST price has a max estimate of 65.00 USD and a min estimate of 40.00 USD. Watch TWST chart and read a more detailed Twist Bioscience Corporation stock forecast: see what analysts think of Twist Bioscience Corporation and suggest that you do with its stocks.
TWST reached its all-time high on Jan 21, 2021 with the price of 214.07 USD, and its all-time low was 11.46 USD and was reached on May 2, 2023. View more price dynamics on TWST chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
TWST stock is 5.11% volatile and has beta coefficient of 2.48. Track Twist Bioscience Corporation stock price on the chart and check out the list of the most volatile stocks — is Twist Bioscience Corporation there?
Today Twist Bioscience Corporation has the market capitalization of 2.20 B, it has decreased by −1.91% over the last week.
Yes, you can track Twist Bioscience Corporation financials in yearly and quarterly reports right on TradingView.
Twist Bioscience Corporation is going to release the next earnings report on May 5, 2025. Keep track of upcoming events with our Earnings Calendar.
TWST earnings for the last quarter are −0.53 USD per share, whereas the estimation was −0.62 USD resulting in a 15.13% surprise. The estimated earnings for the next quarter are −0.55 USD per share. See more details about Twist Bioscience Corporation earnings.
Twist Bioscience Corporation revenue for the last quarter amounts to 88.71 M USD, despite the estimated figure of 86.96 M USD. In the next quarter, revenue is expected to reach 91.99 M USD.
TWST net income for the last quarter is −31.59 M USD, while the quarter before that showed −34.66 M USD of net income which accounts for 8.83% change. Track more Twist Bioscience Corporation financial stats to get the full picture.
No, TWST doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 19, 2025, the company has 923 employees. See our rating of the largest employees — is Twist Bioscience Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Twist Bioscience Corporation EBITDA is −133.93 M USD, and current EBITDA margin is −46.16%. See more stats in Twist Bioscience Corporation financial statements.
Like other stocks, TWST shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Twist Bioscience Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Twist Bioscience Corporation technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Twist Bioscience Corporation stock shows the sell signal. See more of Twist Bioscience Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.